Illumina drives genomic testing as standard of care in oncol

/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research being...

Related Keywords

United States , Chicago , Illinois , American , Nicole Berry , Vivek Subbiah , Shakti Ramkissoon , Pratheesh Sathyan , Phase Drug Development , Prnewswire Illumina Inc , Youtube , Nasdaq , Sarah Cannon Research Institute , Linkedin , Instagram , Facebook , American Society Of Clinical Oncology , American Society , Clinical Oncology , Annual Meeting , Early Phase Drug Development ,